--- title: "Community Health | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 2.825 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/293518407.md" datetime: "2026-07-22T20:36:00.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/293518407.md) - [en](https://longbridge.com/en/news/293518407.md) - [zh-HK](https://longbridge.com/zh-HK/news/293518407.md) generator: "portal-rs" --- # Community Health | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 2.825 B Revenue: As of FY2026 Q2, the actual value is USD 2.825 B, missing the estimate of USD 2.885 B. EPS: As of FY2026 Q2, the actual value is USD 0.51, beating the estimate of USD -0.2. EBIT: As of FY2026 Q2, the actual value is USD 386 M. ### Financial Highlights (Three Months Ended June 30, 2026 vs. 2025) #### Net Income Net income attributable to Community Health Systems, Inc. stockholders was $70 million in 2026, compared to $282 million for the same period in 2025. Excluding adjusting items, net loss attributable to Community Health Systems, Inc. stockholders was - $0.19 per share (diluted) in 2026, compared to - $0.05 per share (diluted) in 2025. #### Adjusted EBITDA Adjusted EBITDA was $330 million in 2026, compared to $380 million for the same period in 2025. #### Net Cash Provided by Operating Activities Net cash provided by operating activities was $87 million for both periods. #### Operating Expenses - Salaries and benefits were $1.237 billion (43.8% of net operating revenues) in 2026, compared to $1.327 billion (42.4%) in 2025. - Supplies were $401 million (14.2%) in 2026, compared to $469 million (15.0%) in 2025. - Other operating expenses were $799 million (28.3%) in 2026, compared to $885 million (28.1%) in 2025. - Lease cost and rent were $63 million (2.2%) in 2026, compared to $74 million (2.4%) in 2025. - Depreciation and amortization were $108 million (3.8%) in 2026, compared to $105 million (3.4%) in 2025. - Impairment and (gain) loss on sale of businesses, net, was - $172 million (-6.1%) in 2026, compared to - $239 million (-7.6%) in 2025. - Total operating expenses were $2.436 billion (86.2%) in 2026, compared to $2.621 billion (83.7%) in 2025. - Income from operations was $389 million (13.8%) in 2026, compared to $512 million (16.3%) in 2025. - Interest expense, net, was $206 million (7.3%) in 2026, compared to $214 million (6.8%) in 2025. - Loss (gain) from early extinguishment of debt was $5 million (0.2%) in 2026, compared to - $138 million (-4.4%) in 2025. - Provision for income taxes was $76 million (2.7%) in 2026, compared to $118 million (3.8%) in 2025. - Net income attributable to noncontrolling interests was $34 million (1.2%) in 2026, compared to $38 million (1.2%) in 2025. ### Financial Highlights (Six Months Ended June 30, 2026 vs. 2025) #### Net Income Net income attributable to Community Health Systems, Inc. stockholders was $12 million in 2026, compared to $269 million for the same period in 2025. #### Adjusted EBITDA Adjusted EBITDA was $638 million in 2026, compared to $756 million for the same period in 2025. #### Net Cash Used in Operating Activities Net cash used in operating activities was - $209 million in 2026, compared to net cash provided of $208 million in 2025. #### Operating Expenses - Salaries and benefits were $2.559 billion (44.1% of net operating revenues) in 2026, compared to $2.699 billion (42.9%) in 2025. - Supplies were $843 million (14.6%) in 2026, compared to $958 million (15.2%) in 2025. - Other operating expenses were $1.627 billion (28.1%) in 2026, compared to $1.750 billion (27.8%) in 2025. - Lease cost and rent were $132 million (2.3%) in 2026, compared to $142 million (2.3%) in 2025. - Depreciation and amortization were $222 million (3.8%) in 2026, compared to $211 million (3.4%) in 2025. - Impairment and (gain) loss on sale of businesses, net, was - $262 million (-4.5%) in 2026, compared to - $263 million (-4.2%) in 2025. - Total operating expenses were $5.121 billion (88.4%) in 2026, compared to $5.497 billion (87.4%) in 2025. - Income from operations was $669 million (11.6%) in 2026, compared to $795 million (12.6%) in 2025. - Interest expense, net, was $419 million (7.3%) in 2026, compared to $432 million (6.9%) in 2025. - Loss (gain) from early extinguishment of debt was $12 million (0.2%) in 2026, compared to - $138 million (-2.2%) in 2025. - Provision for income taxes was $165 million (2.8%) in 2026, compared to $160 million (2.5%) in 2025. - Net income attributable to noncontrolling interests was $67 million (1.2%) in 2026, compared to $76 million (1.2%) in 2025. ### Operational Metrics (Three Months Ended June 30, 2026 vs. 2025) - Consolidated admissions were 86,715 in 2026, an -11.4% change from 97,902 in 2025, while same-store admissions increased 1.9% to 84,001 in 2026 from 82,455 in 2025. - Consolidated adjusted admissions were 196,917 in 2026, an -11.7% change from 223,083 in 2025, with same-store adjusted admissions increasing 2.9% to 191,510 in 2026 from 186,089 in 2025. - The number of hospitals at period end was 60 in 2026, down from 70 in 2025; licensed beds were 8,863 in 2026, down from 10,478 in 2025; and beds in service were 7,665 in 2026, down from 8,983 in 2025. - The occupancy rate (average beds in service) was 52.5% in 2026, up from 50.8% in 2025. ### Operational Metrics (Six Months Ended June 30, 2026 vs. 2025) - Consolidated admissions were 181,237 in 2026, an -11.1% change from 203,839 in 2025, with same-store admissions flat at 169,100 in 2026 compared to 169,116 in 2025. - Consolidated adjusted admissions were 403,314 in 2026, an -11.1% change from 453,779 in 2025, while same-store adjusted admissions increased 1.0% to 376,842 in 2026 from 372,928 in 2025. - The number of hospitals at period end was 60 in 2026, down from 70 in 2025; licensed beds were 8,863 in 2026, down from 10,478 in 2025; and beds in service were 7,665 in 2026, down from 8,983 in 2025. - The occupancy rate (average beds in service) was 55.9% in 2026, up from 54.4% in 2025. ### Cash Flows from Investing Activities (Six Months Ended June 30, 2026 vs. 2025) Net cash provided by investing activities was $1.000 billion in 2026, compared to $786 million in 2025. This included $1.218 billion in proceeds from disposition of hospitals and other ancillary operations in 2026, up from $1.013 billion in 2025. Purchases of property and equipment were - $152 million in 2026, compared to - $176 million in 2025. ### Cash Flows from Financing Activities (Six Months Ended June 30, 2026 vs. 2025) Net cash used in financing activities was - $902 million in 2026, compared to - $575 million in 2025. Repayments of long-term indebtedness were - $1.544 billion in 2026, compared to - $3.380 billion in 2025. ### Other Key Financial Indicators Community Health Systems, Inc. repurchased approximately $368 million principal amount of its 4.750% Senior Secured Notes due 2031 and approximately $231 million principal amount of its 10.875% Senior Secured Notes due 2032 using cash from recent divestiture proceeds. During 2026, the Company divested an 80% ownership interest in one hospital and eight other hospitals. At June 30, 2026, Community Health Systems, Inc. had no outstanding borrowings and approximately $751 million of additional borrowing capacity under its ABL Facility. ### Outlook / Guidance (Year Ending December 31, 2026) Community Health Systems, Inc. projects net operating revenues between $11.400 billion and $11.600 billion, with Adjusted EBITDA expected to range from $1.300 billion to $1.375 billion. The company anticipates a net loss per share (diluted) between - $1.25 and - $1.10 and projects net cash provided by operating activities to be between $300 million and $500 million. Capital expenditures are estimated to be between $350 million and $400 million for the year. ### Related Stocks - [CYH.US](https://longbridge.com/en/quote/CYH.US.md) ## Related News & Research - [Community Health Systems to Participate in 2026 RBC Capital Markets Global Healthcare Conference | CYH Stock News](https://longbridge.com/en/news/286283423.md) - [Community Health Q2 revenue falls more than expected, hurt by sale of hospitals](https://longbridge.com/en/news/293517458.md) - [Why did PANW, NET, HPQ stocks jump to 52-week highs today?](https://longbridge.com/en/news/295874571.md) - [How to Build an AI Portfolio That Actually Holds Up](https://longbridge.com/en/news/295846385.md) - [Christopher John Zegarelli Sells 2,257 Shares of Silvaco Group (NASDAQ:SVCO) Stock](https://longbridge.com/en/news/295857683.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**